Cerebras Systems (CBRS) Stock Slides 23% Since IPO as Wall Street Targets 46% Rally

Key Takeaways

• Atif Malik from Citi launched coverage on CBRS with a Buy recommendation and an ambitious $340 price target, representing potential gains of 45.9%.
• Craig-Hallum joined with its own Buy rating and $325 target, emphasizing that Cerebras’ wafer-scale chip architecture outpaces rival AI inference platforms in speed.
• Shares of CBRS declined 3.09% during Tuesday’s session, bringing total losses to 23.54% from its $350 IPO price on May 14.
• Major tech players OpenAI and Amazon have both chosen Cerebras for AI inference deployments within the last half-year.
• The Street consensus stands at Strong Buy across 10 analyst ratings, with a mean target price of $294—suggesting approximately 27.69% appreciation from current trading levels.

---

Shares of Cerebras Systems (CBRS) debuted on public markets May 14, 2026, at an offering price of $350. In the weeks since, the stock has tumbled 23.54%, hovering near $233 by Tuesday’s close.

Cerebras Systems Inc., CBRS

Yet despite the downturn, Wall Street remains decidedly optimistic.

Citi analyst Atif Malik launched coverage with a Buy stance and established the Street’s most aggressive price objective at $340. From current pricing, that implies upside potential approaching 46%.

Craig-Hallum wasn’t far behind, rolling out its Buy rating alongside a $325 forecast. The firm emphasized Cerebras‘ proprietary wafer-scale architecture, arguing it provides superior inference performance compared to existing AI hardware solutions.

[[LINK_START_2]]Cerebras[[LINK_END_2]] engineered the industry’s first wafer-scale processing system—a single chip utilizing an entire silicon wafer instead of conventional diced components.

Malik’s thesis anticipates Cerebras securing between 40% and 50% of the rapid inference segment. Given his estimated total addressable market of $130 billion, that translates to a revenue opportunity spanning $52 billion to $65 billion.

Craig-Hallum projects an even more expansive outlook—forecasting the AI inference sector will surpass $250 billion before 2030.

Strategic Partnerships With Tech Giants

Both [[LINK_START_3]]OpenAI[[LINK_END_3]] and Amazon have adopted Cerebras technology for inference workloads over the past six months. According to Craig-Hallum, these high-profile endorsements validate Cerebras as a credible competitor in the space.

The firm emphasized that latency and throughput are increasingly critical factors—noting that recent AI models command premium pricing specifically for accelerated inference capabilities.

Cerebras reported trailing twelve-month revenue of $510 million, reflecting 76% year-over-year growth. Notably, the company has already achieved profitability.

Such financial performance is uncommon for newly public technology companies.

Broader Analyst Enthusiasm

Multiple additional research shops launched coverage alongside Citi and Craig-Hallum.

Needham assigned a Buy rating with a $300 objective, underscoring Cerebras’ exclusive market position as the only producer of Wafer-Scale Engine processors. Rosenblatt echoed the Buy call at $300, praising the capabilities of its third-generation platform.

Wedbush initiated with an Outperform rating and $270 target. Mizuho also went Outperform, setting a $300 forecast. Barclays entered at Overweight with a $280 price point.

All told, 10 analysts have weighed in with a unanimous Strong Buy consensus. The average target price across the group lands at $294.

Tuesday’s trading activity was relatively subdued with approximately 1.75 million shares changing hands—considerably lighter than the stock’s typical volume around 25 million.

Barclays underscored the strategic importance of the OpenAI and Amazon partnerships in establishing Cerebras’ credibility within the competitive AI chip landscape.